Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Report: VCs put more into fewer medtech deals last year
Venture capitalists put more cash into fewer deals backing medical device companies last year, according to the MoneyTree report, meaning that the average deal value rose nearly 28% in 2014.
The report, compiled by PricewaterhouseCoopers and the National Venture Capital Assn. using data from Thomson Reuters, found that VC shops spent $2.66 billion on 319 medtech firms. That’s an increase in total value of 27.0% over 2013, but a -0.6% decline in deal volume. Read more
2. Samsung leads $20m round for EarlySense
Samsung Electronics’ venture arm led a $20 million round for EarlySense, a maker of contact-free health monitoring systems.
Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber added to the $10 million put up by Samsung Ventures, according to a press release. Read more
1. Diabetes: Medtronic launches MiniMed 640G
Medtronic said that it’s putting its next generation of insulin management system, the MiniMed 640G, on the global marketplace.
The new system uses Medtronic’s “SmartGuard” technology, designed to suspend insulin delivery when it senses that the patient’s glucose levels are headed toward a low limit, then resume delivery once glucose levels recover, according to a press release Read more
